Training Programs: - McGovern Medical School



Curriculum Vitae 11/10/2019ISIS W. GAYED, MDPRESENT TITLE:Professor of RadiologyUniversity of Texas Medical School at HoustonADDRESS:Department of Diagnostic and Interventional Imaging6431 Fannin, MSB 2.130BHouston, Texas 77030CITIZENSHIP:US CitizenshipCanadian CitizenshipGRADUATE EDUCATION:MBBS, 1986Faculty of MedicineThe University of KhartoumKhartoum, SudanMichener Institute for Applied Health Sciences Center, 1990Toronto, CanadaPOSTGRADUATE TRAINING:Observer, Emergency Department, 1988 – 1989Toronto General HospitalOntario, CanadaInternship, Internal Medicine, 1994 – 1995Hahnemann University HospitalPhiladelphia, PA.Residency, Nuclear Medicine, 1995 – 1997Baylor College of MedicineHouston, TexasFellowship, Nuclear Medicine, 1997 – 1998Baylor College of MedicineHouston, TexasACADEMIC AND ADMINISTERATIVE APPOINTMENTS:Medical Evaluator, 1990-93Bureau of Medical DevicesHealth CanadaAssistant Professor of Radiology, 1998 – 2001Department of Diagnostic and Interventional Imaging, Division of Nuclear MedicineThe University of Texas Medical School - HoustonHouston, TexasACADEMIC AND ADMINISTERATIVE APPOINTMENTS CONTINUED:Assistant Professor, 2001 – 2008Director of Cardiovascular Nuclear MedicineDepartment of Nuclear MedicineUT-M.D. Anderson Cancer CenterHouston, TexasAssociate Professor of Radiology, 2008 – 2015Chief of Nuclear Medicine SectionDepartment of Diagnostic and Interventional RadiologyThe University of Texas Medical School – HoustonHouston, TexasProfessor of Radiology, 2015 – 2019Chief of Nuclear Medicine SectionDepartment of Diagnostic and Interventional RadiologyThe University of Texas Medical School – HoustonHouston, TexasACADEMIC AND ADMINISERATIVE ACHEIMENTS AT M.D. ANDERSON CANCER CENTER:Created a collaborative work environment and work schedule between Nuclear Medicine and Cardiology DepartmentsDeveloped templates for consistent reporting of Nuclear Cardiology studies between Nuclear Medicine and Cardiology.Supervised the daily work flow in Nuclear Cardiology lab.Investigate the effect of radiation therapy on myocardial perfusion studies in collaboration with radiation oncology which led to more conservative radiation planning to avoid the heart.ACADEMIC AND ADMINISERATIVE ACHEIMENTS AT UT- HEALTH SCIENCE CENTER AT HOUSTON:Developed the PET Center at Out-Patient Imaging and Diagnosis (OPID) in the Medical anized and increased the number or PET studies performed at OPID for oncology and neurology studies.Introduced SPECT-CT imaging technology to Harris Health System by acquiring the first SPECT-CT camera in the Nuclear Medicine lab at LBJ hospital.Increased volume and variety of nuclear medicine studies performed in nuclear medicine at Memorial Hermann hospital and OPID-medical center through friendly visitation and consultation with other department.Increased the number and variety of therapies with radionuclides in collaboration with Oncology, and Endocrinology.Increase in the duration of radiology resident rotations through MHH nuclear medicine section for better exposure to our growing number and variety of nuclear medicine studies and therapies with better learning experience and teaching environment.Initiated collaboration with Baylor nuclear medicine physicians and radiologists for interpretation of PET studies performed at Smith clinic, Harris Health imaging center.HOSPITAL APPOINTMENTS:Staff Radiologist, 1998-2001Nuclear MedicineMemorial Hermann HospitalHouston, TexasStaff Radiologist, 1998-2001Lyndon B. Johnson HospitalHouston, TexasDirector, 2001-2008Cardiovascular Nuclear MedicineDepartment of Nuclear MedicineUT – MD Anderson Cancer CenterHouston, Texas Staff Nuclear Medicine Physician, 12/2008 – PresentChief, Nuclear MedicineMemorial Hermann HospitalHouston, TexasStaff Nuclear Medicine Physician, 12/2008 – PresentChief, Nuclear MedicineLyndon B. Johnson HospitalHouston, TexasLICENSURE:Texas Medical License # K4064, 1995-presntIndiana Medical License # H969213, 2004CERTIFICATION:American Board of Nuclear Medicine, 1997Maintenance of Certification Exam, 2007Certification Council of Nuclear Cardiology, 1998Certification in Coronary CTA Interpretation, 2008Maintenance of Certification Exam, 2019PROFESSIONAL ORGANIZATIONS:Local:Member, St. Mark Medical Society, 1995-2000Member, Harris County Medical Society, 1997-2005Member, Association for Women Faculty, 1999 – presentMember, M.D. Anderson Cancer Center Alumni, 2001 - presentMember, Baylor College of Medicine Alumni, 2002 - presentState:Member, Texas Medical Association, 1997-2005Texas Medical Board - 2009National:Member, Society of Nuclear Medicine, 1998-presentMember, SW Chapter, Society of Nuclear Medicine, 1998-present Leadership Roster, Southwest Chapter of the Society of Nuclear Medicine, 1999Member, Women in Nuclear Medicine, SNMMI, 2014-presentMember, Physician Organization of Women, 2013-presentMember, American College of Nuclear Physicians, 2001 - 2002Member, American Society of Nuclear Cardiology, 2001-2009 Member, Academy of Molecular Imaging, 2002-2003Member, European Association of Nuclear Medicine, 2004-2007Member, Society of Coronary Computed Tomography, 2008-2009Member, American College of Radiology, 2013 – 2014HONORS AND AWARDS:Award of Excellence in all Egyptian Schools in Sudan and Somalia, 1979Final Top Score in High School ExamsHonor Graduate of Michener Institute for Applied health Sciences, 1990Nuclear Medicine Technology ProgramToronto, CanadaMallinckrodt Award, 1991Highest mark in Nuclear Medicine Technology ExamVanguard Urologic Research Foundation Award, 2012Houstonia Top Doctors listing, 2013Selected by peer clinicians in Houston as one of two top doctors for Nuclear Medicine specialty.EDITORIAL POSITIONS:Editor-in-Chief, Research and Reports in Nuclear Medicine - 2011- 2014.Editorial Board Member, Austin Journal of Nuclear Medicine and Radiotherapy-2014- Present.Editorial Board Member, Journal of Radiology or Imaging Diagnosis- 2017-presentEditorial Baord Member, Journal of Nuclear Medicine and Clinical Imaging- 2019-presentBook Reviewer:Nuclear Cardiology and Correlative Imaging, J Nucl Med.; 46(8):1401, August, 2005.Clinical PET and PET/CT, J Nucl Med. 47(4):726, April, 2006.Atlas of Non-Invasive Coronary Angiography by Multidetector Computed Tomography. J Nucl Med, 49 (8):1398, August, 2008.Myocardial Perfusion Scintigraphy: From Request to Report. J Nucl Med. 50(3): 488, Feb. 2009. Abstract Reviewer:Southwest Chapter Society of Nuclear Medicine Meeting, 1998Society of Nuclear Medicine -Cardiovascular-Basic Science Section, 2002Society of Nuclear Medicine – Clinical Diagnosis/Oncology, 2003Society of Nuclear Medicine – Cardiovascular-Basic Science Section, 2004Society of Nuclear Medicine – Cardiovascular-Basic Science Section, 2005Society of Nuclear Medicine – Cardiovascular-Clinical Section, 2006Society of Nuclear Medicine – Cardiovascular-Clinical Section, 2007Manuscript Reviewer:European Journal of Nuclear Medicine and Molecular Imaging Research 2019Journal of Neurological Therapeutics, 2016 The Journal of Nuclear Medicine, 2000- presentThe Journal of Nuclear Medicine Technology, 2014-presentAustin Radiology, 2014-presentWest African Journal of Radiology, 2012-presentThe Journal of Coronary CT, 2008Journal of Postgraduate Medicine, 2005Anti-Cancer Drugs Journal, 2004The International Journal of Radiation Oncology, Biology, Physics, 2003Breast Diseases: A Year Book Quarterly, 2002Advisor:Advisor for Scientific Publications Department, UT- M.D. Anderson Cancer Center, 2007-2008.Global Health Scholarly Concentration General Advisor, MacGovern Medical School, 2016.SERVICE ON THE UNIVERSITY OF TEXAS, MD ANDERSON CANCER CENTER COMMITTEES:Medical Practice Subcommittee, 2001Senate Representative of the Nuclear Medicine Department, 2006-2008Member of the Promotion and Tenure Subcommittee, 2006-2008Organization of Clinical Nuclear Medicine Seminars, UT- MD Anderson Cancer Center, - 2007 – 2008.SERVICE ON THE UNIVERSITY OF TEXAS, UT - HEALTH McGOVERN MEDICAL SCHOOLMember of FAPTC Ad-hoc committee, 2018 – presentMember of Panel 2 committee – CPHS of UT-Health in Houston, 2018 - presentSERVICE ON THE DEPARTMENT OF DIAGNOSTIC AND INTERVENITIONAL IMAGING COMMITTEES:Member of the Research Committee, 2012-2015Organizer Quality Control Meeting for Nuclear Medicine Section, 2013-presentAdministrator and supervisor of UT Health Radiology Face Book site, 2016-presentFounder of the Improvement of cash, international and philanthropy collection (ICIP) committee for the Department of Diagnostic and Interventional Imaging. 2018SERVICE TO COMMUNITY AND GLOBAL HEALTH:Questions and Answers: Thyroid Cancer, Patient Education Brochure for the public, 9/2003Radio Interview for ASTRO meeting in Los Angeles, CA - 2007Director of H.O.P.E. (Help Other People Excel) non-profit charity organization 2008 - 2011Founder and Director, the Good Samaritan Service, a non-profit charity organization, 2011-presentActivist against Female Genital Mutilation (FGM) in Africa, the Good Samaritan Service 2016.SPECIAL TEACHING AND MENTORING ACTIVITES AT UNIVERSITY OF TEXAS - MD ANDERSON CANCER CENTERCaptopril and Lasix renal scan analysis. Department of Nuclear Medicine, UT-MD Anderson Cancer Center, Houston, TX, 10/2001Cardiac PET, UT-MD Anderson Cancer Center, Houston, TX, 4/2003Residents Didactic Lectures:Cardiac Imaging Agents, 01/2002Cardiac Functional Imaging, 04/2002Myocardial Imaging Agents, 05/2002Myocardial Perfusion Reports, 11/2002Nuclear Medicine Review, 04/2003Myocardial Perfusion Imaging Protocols, 11/2004Challenging Cardiac Cases, 2/05Artifacts in Nuclear Medicine Imaging, 11/8/2005Stress Myocardial Perfusion Imaging, 1/07Radiopharmaceuticals for myocardial perfusion imaging, 12/2007Ventilation and Perfusion Lung Scans 9/2009Imaging of NET in Nuclear Medicine 6, 2018Training Programs:Breast Lymphatic Mapping Course, American College of Surgeons Oncology Group, University of Texas – MD Anderson Cancer Center, Houston, TX, 09/26-27/02.Other Educational Programs:Unsealed Sources-Pain Palliation. Radiation Oncology Residents Lecture Series. 3/2005Nuclear Medicine Physician In-service. Lung Perfusion Score for 3D Lung Quantitative studies, 7/2007Nuclear Medicine Physician In-service. Hologic Whole Body Composition Studies, 10/2007 Nuclear Medicine Physician In-service, Myocardial perfusion defect size, 4/2008Journal Club, Nuclear Medicine Specialty - Mentoring Radiology residents 9/2017PET-CT of the Brain: A Case-Based Review. Electronic educational exhibit at the ASNR 56th Annual meeting by Whitney Boyce and Isis Gayed. 6/2018Supervisory Research:College Student, Research Programs in Biomedical Sciences, UT-MD Anderson Cancer Center, Summer 2002, 2004, 2006Medical School Student, Summer Research Program, UT-MD Anderson Cancer Center, Summer 2006High School Student, Summer Research Program, UT-MD Anderson Cancer Center, Summer 2006Mentor - Volunteer Research Assistant Physician, UT-MD Anderson Cancer Center, 10/06-4/2006Mentor - Physician Research Intern, UT-MD Anderson Cancer Center, 6/07-4/08Mentor - Research College Student (C.U.R.E program), UT-MD Anderson Cancer Center, 6/08-8/08SPECIAL TEACHING AND MENTORING ACTIVITES AT UNIVERSITY OF TEXAS MEDICAL SCHOOL - HOUSTONResidents Lectures:Cardiac Nuclear Medicine I, 03/2000Cardiac Nuclear Medicine II, 03/2000Renal Radiopharmaceuticals, 10/2000Effect of Medications on Nuclear Medicine Scans, 11/2000Different Cardiac Imaging Protocols, 02/2001Yearly Board Reviews for Radiology Residents, UT Medical School, 2003-2015PET-CT Hands-on Training. 2009-present.General Nuclear Medicine and PET Teaching Case Manual for Radiology Residents, 2013 Annual Fundamentals Lectures in Nuclear Medicine 2009-2019Parathyroid Imaging and Interpretation Made Easy, 9/2016PET Imaging of Neuroendocrine Tumors 6/2018Supervisory Research:Mentor - Research college student, UTHSC at Houston, Jun-Aug, 2009Mentor- Research pre-medical school volunteer, 2010Mentor- Research assistant, Nuclear Medicine Section, 2013-2014Mentor- Nursing student research volunteers, May-Aug, 2015Mentor- Summer high school student volunteer, May-Aug, 2015Mentor- Casual research assistant physician, April, 2016 – Jan, 2018Mentor- Radiology residents research projects, May, 2016 to presentMentor- Graduate medical doctor at the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Science, June, 2018.Mentor- Body imaging fellow for research projects, 2017Mentor- Neuroradiology fellow for research project, 2018 to -2019Mentor- Pre-bachelorette Research Trainee, summer of 2018 and 2019.Poster Exhibit:Advances in Nuclear/Molecular Imaging Poster, Department of Diagnostic and Interventional Radiology June, 2015Correlation of Quantitative Analysis and Focal Hypometabolism on FDG PET Scan to Cortical Resection of Seizure Focus in Refractory Epilepsy, SNMMI Annual Meeting, Philadelphia June, 2018Interdepartmental Activities:Endocrine Multidisciplinary Conference2010- presentLiver Conference2014 – presentRUN conference2014 – presentRadiology Working Group, Oncology Section2014 – presentHead and Neck Multidisciplinary conference2016 - presentSPECIAL TEACHING ACTIVITES OUTSIDE THE UNIVERSITY:Radiology Oral Board Reviews. Osler Institute 5/2012Radiology Recertification Board Review. Osler Institute, 7/2012Radiology Oral Board Reviews. Osler Institute, 6/2013TEACHING RESPONSIBILITIES:Direct Supervision:Undergraduate and Allied Health StudentsNuclear Medicine Technology Students, Houston Community College, 2001-present.Radiology Residents and Fellows:Residents, General and Cardiovascular Nuclear Medicine, 1998-PresentResidents, Positron Emission Tomography, 2001-Present.Endocrine Fellows:Teaching endocrine nuclear medicine. 2009-presentMedical Students:Didactic lecture for the medical students Oct, 2018Teaching Medical students rotating though Nuclear Medicine 2018-presentWorld Wide Wednesday (WWW) Teaching Faculty:Helped develop WWW global health curriculum.PAST GRANT SUPPORT: P.I.: Lamk M. Lamki, MDCo-Investigator: Isis Gayed, MDEvaluation of the Safety and Efficacy of 99m-Tc-Labeled Anti-Granulocyte Antibody Fab’ Fragment (IMMU-MN3) for the Diagnosis of Osteomyelitis in Patients with Diabetic Foot Ulcers, IM-D-MN3-07, IND Number BB3579$11,874.00 (plus radiopharmaceuticals from company) 4//1993-4/1994P.I.: Lamk M. Lamki, MDCo-Investigator: Isis Gayed, MDEvaluation of the Safety, Efficacy, and Cost-Effectiveness of LeukoScan-TM (99m-Tc-Labeled Anti-Granulocyte Antibody Fab’ Fragment – IMMU-MN3) in the Detection of Acute Non-Classic Appendicitis IM-D-MN3-16$140,000 12/1994 – 5/2001P.I.: Lamk M. Lamki, MDCo-Investigator: Isis Gayed, MDThe Utility of 99m-Tc-IMMU-LL2 Fab’ SH Fragment Imaging in the Detection of Residual Disease after Chemotherapy and/or Radiotherapy in Patients with Intermediate and High Grade Non-Hodgkin’s Lymphoma, IM-D-LL2-05$56,000 per study 12/1996 –5/2001P.I.: C.F. Levenback, MDCo-Investigator: Isis Gayed, MD Feasibility of Combined Intraoperative Lymphatic Mapping and Sentinel Node Identification in Patients with Cervix Cancer ID99-13106/23/1999P.I.: Bruce J. Barron, MDCo-Investigator: Isis Gayed, MDPhase I/II RadioImmunoTherapy of Non-Hodgkin’s Lymphoma with Radiolabeled Humanized IMMU-LL2: Treatment with 90-Y-hLL2lgG, HSC-MS-00-086$28,384.64 2000-2001P.I.: Lamk M. Lamki, MDCo-Investigator: Isis Gayed, MDExpanded Access Study of Iodine-131 Anti-B-1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin’s Lymphoma, CP-98-020$7,000.00. 4/2000-3/2001P.I.: B. Esmaeli, MDCo-Investigator: Isis Gayed, MDSentinel Lymph Node Localization and Biopsy for Conjunctival Melanomas: A Pilot StudyGSP00-106 05/30/2000P.I.: Bruce J. Barron, MDCo-Investigator: Isis Gayed, MDA Phase I/II Study of Radioimmunotherapy with Y-Humanized MN-14 IgG Administered as a Single Dose to Patients with Refractory Advance/Metastatic Pancreatic CarcinomasIM-T-hMN14-03 $70,641.60. 8/2000 – 3/2001P.I.: G.V. Babiera, MDCo-Investigator: Isis Gayed, MDA Preliminary Study to Explore Subareolar Injection as the Site for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients with Breast Cancer, ID01-538$176, 400 (Funded by MDACC Subcommittee for Clinical Research) 2001 - 2006P.I.: D. Bodurka-Bevers, MDCo-Investigator: Isis Gayed, MDFeasibility Study of Intraoperative Lymphatic Mapping and Sentinel Lymph Node Identification in Patients with Endometrial CancerID01-29008/20/2001P.I.: J. Myers, MDCo-Investigator: Isis Gayed, MDPreoperative Lymphoscintigraphy and Intraoperative Lymphatic Mapping for High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck ID01-51512/2001P.I.: C.F. Levenback, MDCo-Investigator: Isis Gayed, MDLymphoscintigraphy in Patients with Vaginal Cancer ID02-239 09/25/2002P.I.: B. Esmaeli, MDCo-Investigator: Isis Gayed, MDRadioimmunotherapy with Y90 Zevalin for Low-Grade Follicular Non-Hodgkin’s Lymphoma of the Orbit 2003-06969/19/2003P.I.: M. Cristofanilli, MDCo-Investigator: Isis Gayed, MD99m Tc-Annexin-V for Imaging of Apoptosis in Primary Breast Cancer,9/29/2003P.I.: Ann Tong, MDCo-Investigator: Isis Gayed, MD A Randomized Double Blind Multicenter study evaluating the effects of Eplerenone versus placebo on ventricular remodeling in Patients with left ventricular systolic dysfunction (EF<35%) and mild to moderate heart failure. 2004-0433 6/2004P.I.: Massimo Cristofanilli, MDCo-Investigator: Isis Gayed, MDProspective trial of Tc-99m EC-Annexin-V for imaging of treatment related apoptosis and prediction of pathological complete response to induction therapy in women with primary breast cancer (PBC), 2004-0220 7/2004P.I.: Charles Levenback, MDCo-Investigator: Isis Gayed, MDLymphatic Mapping and Sentinel Node Identification in Patients with Stage 1B1 Cervical Carcinoma GOG02067/2004P.I.: Bita Ismaeli, MDCo-Investigator: Isis Gayed, MDEvaluation of PET Findings in Orbital and Ocular Adnexal Lymphoma. RCR04-0443 9/2004P.I.: M. Frumovitz Co-Investigator: Isis Gayed, MDHistopathologic Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients with cervical Cancer Undergoing Radical Hysterectomy or Radical Trachelectomy and Pelvic Lymph Node Dissection: A Feasibility Study, 2006-0153 2/14/2006P.I.: R. Komaki Co-Investigator: Isis Gayed, MDA Phase I/II Study of TARCEVA(erlotinib) in Combination with Chemoradiation in Patients with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC), 2005-1023 6/6/2006P.I.: M. Ross Co-Investigator: Isis Gayed, MD A Phase2, Single Arm, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of Lymphoseek as a Lymphoid Tissue Targeting Agent in Patients with Known or Suspected Melanoma or Breast Cancer Who are Undergoing Lymph Node Mapping, 2006-0489 7/2006P.I.: K. Basen-EngquistCo-Investigator: Isis Gayed, MDWeight Gain Prevention for Breast Cancer Survivors. 2005-08884/16/2007P.I.: Isis Gayed, MDRadiation Therapy and Cardiac Enzymes. 2007-0489,5/29/2007P.I.: M. Ross MCo-Investigator: Isis Gayed, MDA Follow-up Study of Breast Cancer and Melanoma Patients that Participated in the Phase 2 Clinical Study for Lymphoseek, DR08-00852/8/2008P.I.: M. Ross Co-Investigator: Isis GayedA Phase 3, Prospective, Open Label, Multicenter Comparison Study of Lymphoseek and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients with Known Melanoma and Breast Cancer who are Undergoing Lymph Node Mapping2/2008P.I.: P. Ramirez PCo-Investigator: Isis GayedA Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer. 2007-08004/4/2008P.I.: B. Esmaeli Co-Investigator: Isis GayedSentinel Lymph Node Localization and Biopsy for Sebaceous Gland Carcinoma of the Eyelid. 2008-0266,4/28/2008P. I.: Isis GayedSeecureA Pilot Study of Biodistribution and Dosimetry of 99m Tc-Glycopeptic (99m Tc-GP) in Patients with Breast CancerHSC-MS-09-0536$114,000.00 01/2010 - P.I. Kevin SlawinCo-Investigator: Isis GayedA Phase I Pilot Study Comparing I-MIP-1072 Versus In-111 Capromab Pendetide in Subjects with Metastatic Prostate Cancer.HSC-MS-10-0391Amount: $ 10,790 05/2010P.I.: Kevin SlawinCo-Investigator: Isis GayedA Phase 1 Pilot Comparison Study of 99mTc-MIP-1404 Single PhotonEmission Computed Tomography (SPECT)/CT Imaging to Histology inMen with High-Risk Prostate Cancer.Amount: $ 9,340 2/2012P.I.: Kevin SlawinCo-Investigator: Isis GayedA Phase 2 Assessment of the Diagnostic Accuracy of 99mTc-MIP-1404 Imaging in Men with High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pelvic Lymph Node Dissection (EPLND) Compared to Histopathology. HSC-GEN-12-0350.Amount: $ 225,949.50 06/2012P.I.: Kevin SlawinCo-Investigator: Isis GayedA Randomized Phase 2 trial of 177 Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in patients with High- Risk Castrate biochemically Relapsed Prostate Cancer after Local TherapyAmount: $ 7,656/patient 06/2013P.I.: Isis GayedEvaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively.HSC-MS-16-0015Amount: $6000 3/2016 - presentP.I.: Paul SchultzCo-Investigator: Isis GayedImaging Dementia—Evidence for Amyloid Scanning (IDEAS) StudyHSC-MS-15-0922Amount: $4000/patient 2016 - 2017P.I.: Beth ScholtzCo-Investigator.: Isis GayedTreatments Against Rheumatoid Arthritis and Effect on FDG PET-CT: The TARGET TrialHCS-MS-17-0082Novartis Funded 2/2017-presentP.I.: Joseph LucciCo-Investigator: Isis GayedA randomized phase II trial of radiation therapy and cisplatin alone or in combination with intravenous triapine in women with newly diagnosed bulky stage IB2, stage II, IIIB, or IV A cancer of the uterine cervix or stage II-IV A vaginal cancer. HSC-MS-16-0320Funded by the National Cancer Institute 1/19/2018-present.P.I.: Ernest ConradCollaborator: Isis GayedA Phase 2, randomized, Double-Blind, Placebo-Controlled Efficacy and safety study of Palovarotene in subjects with multiple osteochondromas. HSC-MS-18-0597 10/26/2018-presentFunded by Clementia Pharmaceuticals, Inc.P.I.: Absalon GutierrezCo-Investigator: Isis GayedGLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response.HSC-MS-19-0787Funded by NIH 7/1/2019-6/30/2022UNFUNDED PROTOCOLS:Principle Investigator, Comparison of Bone and F-18 FDG Scans in the Evaluation of Bony Metastases, RCR01-622, Gayed, Isis, 10/2001Principle Investigator, Effect of Iterative Reconstruction on Left Ventricular Ejection Fraction and Volumes, RCR02-726, Gayed, I, 12/6/2002. Principle Investigator, Staging Melanoma Using Positron Emission Study as The Sole Study, RCR02-018,Gayed, Isis, 1/2002-1/2003Principle Investigator, F-18 FDG PET Accuracy in Detection of Gastrointestinal Stromal Tumors (GIST), RCR02-578, Gayed, I, 5/13/2003Principle Investigator, Investigation of the Usefulness of SPECT/CT in the Evaluation of Parathyroid Adenoma, RCR03-1034, Gayed, I, 1/12/2004Principal Investigator, The role of Myocardial Perfusion Imaging in Perioperative Risk Stratification of Cancer Patients, RCR04-0115, Gayed I, 2/24/2004Principle Investigator, Detection of Ischemia in Patients with Blunted Hemodynamic Response to Adenosine Stress, RCR04-0343, Gayed I, 4/26/2004Principle Investigator, Comparison Between I-123 MIBG and In-111 Octreotide in the Detection of Neuroendocrine Tumors, RCR04-0287, Gayed I, 5/12/2004Principle Investigator, Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG whole body PET Scans for tumor staging, 2004-0578, Gayed I, 7/20/2004Principle Investigator, Evaluation of Cardiac Uptake of Tc-99m EC-Annexin-V after Chemotherapy for Breast Cancer, 2004-0220, Gayed I, 9/28/2004Principle Investigator, Effect of Radiation Therapy on Myocardial Perfusion in Patients with Esophageal Cancer. RCR05-0764, Gayed I, 9/2005Co-Investigator, Chart Review Study to Assess Vitamin D Status in Patients with PHPT and Effect of Vitamin D Levels on Biochemical and Radiographic Parameters. RCR06-0427, 5/2006Principle Investigator, Effect of Radiation Therapy on Myocardial Perfusion in Patients with Lung Cancer. PCR06-0531, Gayed I, 6/2006Co-Investigator, Comparison of Lung Scan and CT Angiography for the Diagnosis of Pulmonary Thromboembolism in Patients with Cancer. RCR06-0766, Kim E, 9/2006Principle Investigator, Quantitative Parameters for Diffuse Lung Disease Using Lung Perfusion Scans. RCR06-0919, Gayed I, 12/2006Co-Chairman, Coronary Artery Disease and Primary Hyperparathyroidism. DR07-0360, Perrier N, 6/2007Co-Chairman , A Chart Review to Determine the Significance of Isolated posterior Tc-99m ECD Uptake on Cerebral Blood Flow Scintigraphy and its Relationship to Patient Outcome in Brian Death. HSC-MS-09-0099, Joseph U, 4/2009Principle Investigator, Value of SPECT/CT in the Evaluation of Lower Extremity Bony Lesions. HSC-MS-09-0149, Gayed I, 05/2009Co-Investigator, A Humanitarian Device Exemption Use Protocol of TheraSphere ? For Treatment of Unresectable Hepatocellular Carcinoma and Patients with Portal Vein Thrombosis. HSC-MS-08-0489, Cohen A, 11/2009 Principal Investigator: Brain SPECT Findings in Patients with Attention Deficit-Hyperactivity Syndrome. Gayed I, 12/2009Co-Investigator: Gallbladder ejection fraction and the rate of ejection, which one is the better predictor of symptoms relief after cholecystectomy. HSC-MS-09-0538, Wan D, 1/2010Principal Investigator: Retrospective Review of Correlation between EEG and FDG PET Brain Scan in Epilepsy and the Implication on Post-surgical Outcome. HSC-MS-12-0816. 4/20012Principal Investigator: Retrospective Review of DaTscan Performance and Patterns of Abnormalities in Patients with Tremors. HSC-MS-12-0588. 8/2012.Principle Investigator: The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions, HSC-MS-14-0113, 02/2014Principal Investigator: Factors causing discrepancy between parathyroid Sestamibi scan and operative findings. HSC-MS-14-0047, 03/2014Principle Investigator: Quantification of Tc-99m MAA Liver Perfusion as a Predictor of Tumor Response to Hepatic Radioablation.HSC-MS-14-0577, 07/2014Principle Investigator: Coupling of Brain Magnetoelecrtical Activity with Metabolic Activity: A New Innovation in the Era of Hybrid Imaging. HSC-MS-14-0854, 10/21/2014.Co-Investigator: Abdomen and pelvis imaging on PET / CT in head and neck cancers- indicated or not. 11/12/2014.Principle-Investigator: Correlation of Semi quantitative analysis and Focal Hypometabolism on FDG PET Scan to Cortical Resection of Seizure Focus in Refractory Epilepsy. HSC-MS-16-1020, 11/2016.Principle Investigator: Identification of pattern(s) of abnormalities using DaTscan in patients with essential tremor. HSC-MS-17-0365, 04/2017Co-Investigator: Compare the sensitivity and specificity of Leucine analog F18-Fluciclovine PET scan with bone scan to detect prostate cancer bony metastases.HSC-MS- 8/2017Co-Investigator: Lung quantification scintigraphy in the lung transplant patients. : Correlation of patient symptoms with development of defects.? HSC-MS-19-0002, 12/2018Principal Investigator: Evaluation of brain stimulation on PET-CT scans in patients with depression. HSC-MS-19-0003, 3/2019Principal Investigator: Identification of micrometastases from pre-operative lymphoscintigraphy in breast cancer patients. HSC-MS-19-0931, 11/2019.Principal Investigator: The value of repeat Ga-68 Dotatate PET-CT imaging in follow up of neuroendocrine tumors. HSC-MS-19-1034, 10/2019PUBLICATIONS: Abstracts:Frumovitz M., Coleman R., Gayed I, Ramirez P, Wolf J, Levenback C. Utility of Preoperative Lymphoscintigraphy in Patients Undergoing Radical Hysterectomy and Pelvic Lymphadenectomy for Cervical Cancer. Gynecol Oncol 2004;96:990.Helen H Liu, Blackmond S, Gayed I, Wang S, Wei X, Tucker S, Liao Z, Hofstetter W, Swisher S, Komaki R. Cardiac Toxicity from Chemoradiation with and without Surgery for Patients with Esophageal Cancer. Int J Radiat Oncol Biol Phys 66(3):S285-S286, 2006.Fearmonti RM, Gayed IW, Kim E, Waraneke C, Bedrosian I, Hunt KK, Ghonimi E, Meric-Bernstam F, Babiera GV. In vivo comparison of lymphatic drtrainage patterns of subareolar and peritumoral isotope injection for breast cancer. Ann Surg Onc 2007; 14(2):P58. Won K, Gayed I, Namwongprom, E Kim, E Edmund Kim. Practical Criteria of Lung Scan Interpretation for Pulmonary Embolism in Patients with Cancer. J Nucl Med 48 (Suppl) 2:290p, 05/2007.WD Erwin, RE Wendt, S Kappadath, IW Gayed. Principal Component Analysis (PCA)-Based Radionuclide Separation in Simultaneous dual-isotope Tl-201/I-123 Cardiac Imaging. J Nucl Med 48 (Suppl) 2:419p, 05/2007.S Gohar, Z. Liao, S. W. Yusuf, H. H. Liu, I Gayed. Myocardial Perfusion Abnormalities and the subsequent Clinical Implications in Patients with Esophageal and Lung Cancer after Chemoradiation therapy. J Nucl Med 49 (Suppl) 2:199p, 05/2008.Kothari,KD, Joseph,UA, Skolkin, D, David Q Wan, Isis W. Gayed. The Significance of Isolated Posterior Fossa Tc 99m ECD Uptake Seen on Cerebral Blood Flow Scintigraphy and its Relation to Patients’ Outcomes. The American Roentgen Ray Society’s 111th Annual Meeting, May 2, 2011. Chicago. Joseph, UA, Kanatsiz, O, Wan, DQ, Gayed, IW. Same day or next day breast lymphoscintigraphy injection, which works better?. The Society of Nuclear Medicine Annual Meeting, J Nucl Med 52 (Suppl) 1: 405p, 06/2011.Wan, DQ, Slawin, K, Joseph, UA, Tammisetti, V, Santoshi, P, Gayed, I. Initial experience of prostate specific membrane antigen binding agent I-123-MIP-1072 nuclear scan in patients with metastatic prostate cancer: Comparison with bone and CT scans. J Nucl Med 52 (Suppl) 1: 83p, 06/2011. Joseph UA, Karni R., Wan DQ, Gayed IW. PET/CT Imaging of Abdomen and Pelvis in Head and Neck Cancers- Indicated or NOT? WMIC, 9/2016Refereed Original Articles in Journals:Gayed, I, Dhekne, R. A false negative Tc-99m hepatobiliary scan in a patient withOsler-Weber-Rendu disease Clin Nucl Med, 22(10): 712-713, 1997. Gayed IW, Elshazly SM. Intrathoracic splenosis: Status after a motor vehicle accident. Clin Nucl Med. 25 (12): 1045-6, December 2000.Gayed, I, Wendt, J,Haynie, T, Dhekne, R, Moore, W. Timing for repeated treatment of hyperthyroidism with radioactive iodine after initial treatment failure. Clin Nucl Med 26 (1): 1-5, January 2001.Gayed, I, Elshazly, S, et al. Intrathoracic splenosis status post motor vehicle accident. Clin Nucl Med, February 2001.Gayed, I., Elshazly, SM, Vang, RS, Barron, BJ, Lamki, LM. Technetium-99m sestamibi uptake in a maxillary brown tumor. Clin Nucl Med, 26 (1): 65-7, January 2001.Gayed, I, Boccalandro, F, Fang, B, Podoloff, D. New method for calculating right ventricular ejection fraction using gated myocardial perfusion studies. Clin Nucl Med, 27 (5): 334-8, May 2002.Gayed, I, Cid, E, Boccalandro, F, Podoloff, D. Factors affecting left ventricular ejection fraction using automated quantitative gated SPECT. Clin Nucl Med, 28 (4): 290-5 April 2003.Gayed, I, Vu, T, Johnson, M, Macapinlac, H, Podoloff, D. Comparison of bone and 2 – deoxy – 2-[18F] fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer . Mol Imag and Biol, 5 (1):26-31, January 2003.Gayed, I, Vu, T, Iyler, R, Johnson, M, Macapinlacm H, Swanston, N, Podoloff, D. The role of F-18 FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med, 45 (1): 17-21, January 2004.Gayed, I, Kim, EE, Broussard, WF, Evans, D, Lee, J, Broemeling, LD, Ochoa, BB, Moxley, DM, Erwin, WD, Podoloff, DA. The value of Tc-99m sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med, 46 (2): 248-52, February 2005. Frumovitz M, Coleman RL, Gayed IW, Ramirez, PT, Wolf, JK, Gershenson, DM, Levenback, CF. Usefullness of preoperative lymphoscintigraphy in patients undergoing radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol, 194(4):1186-93, April 2006.Kawase K, Gayed I, Hunt KK, Kuerer, HM, Akins, J, Yi,M, Grimes, L, Babiera, GV, Ross, MI, Feig, BW, Ames, FC, Singletary, SE, Buchholz, TA, Symmans, WF, Meric-Bernstam, F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg, 203(1):64-72, July, 2006. Gayed I, Liu H, Yusuf WS, Komaki,E, Wei, X, Wang, X, Chang, JY, Swafford, J, Broemeling, L, Liao, Z. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med, 47(11):1756-62, November 2006. Won KS, Gayed I, Kim EE, Macapinlac, H. Juvenile fibroadenoma of the breast on 111 in-octreotide SPECT and F-18 FDG PET/CT. Eur J Nucl Med Mol Imaging, 34(3):440, March 2007. Chang K, Sarkiss M, Won KS, Swafford J, Broemeling L, Gayed I. Preoperative risk stratification using gated myocardial perfusion studies in patients with cancer. J Nucl Med, 48(3):344-348 March 2007. Gayed I, Burke D, Won KS, et al. Effect of blunted hemodynamic response to adenosine on myocardial perfusion studies. Current Medical Imaging Review, 1:3 (3): 1-4, August 2007. Shioyama, Y, Jang, SY, Liu, HH, Guerrero, T, Wang, X, Gayed, IW, Erwin, WD, Liao, Z, Chang, JY, Jeter, M, Yaremko, BP, Borghero, YO, Cox, JD, Komaki, R, Mohan, R. Preserving functioning lung using perfusion imaging and intensity-modulated radiation therapy for advanced stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1;68(5):1349-58, August 2007. Gayed, I, Eskandari, MF, McLaughlin, P, Pro, B, Diba, R, Esmaeli, B. Value of positron emission tomography in staging ocular adrenal lymphomas and evaluating their response to therapy. Ophthalmic Surg Lasers Imaging, 38(4):319-25, July 2007.Fumovitz, M, Gayed I, Jhingran A, Euscher, ED, Coleman, RL, Ramirwz, PT, Levenback, CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol, 108(3):478-81, March 2008. Won KS, Kim EE, Mar M, Erwin W, Wei W, Gohar S, Gayed I. Is iterative reconstruction an improvement over filtered back projection in processing gated myocardial perfusion SPECT?. The Open Medical Imaging Journal, 2(1):17-23, February 2008. Gayed I, Joe Chang, E. Edmund, Kim, EE, Nunez, R, Chasen, B, Liu, HH, Kobayashi, K, Zhang,Y, Liao, Z, Gohar, S, Jeter, M, Henderson, L, Erwin, W, Komaki, R.. Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol, 3(8):858-64, August 2008. Gayed I, Liu, HH, Wei, Z, Liao, Z, Yusuf, SW, Chang, JY, Bassett, R, Lomaki, R, Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. J Thorac. Oncol, 4(2):179-84, February 2009. Esmaeli, B, McLaughlin, P, Pro, B, Samaniego, F, Gayed, I. Hagemister, F, Romaguera, J, Cabanillas, F, Neelapu, SS, Banay, R, Fayad, L, Saville,WM, Kwak, LW. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol, 20 (4):709-14, April 2009.Gayed, I, Gohar, S, Liao, Z, McAleer, M, Bassett, R, Yusuf, SW: The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy. Int J Cardiovasc Imaging, 25 (5):487-495, June 2009.Perrier, ND, Edeiken, B, Nunez, R, Gayed, I, Jimenez,C, Busaidy, N, Potylchansky, E, Kee, S, Vu,T. A novel nomenclature to classify parathyroid adenomas. World J Surg, 33(3):412-6, March 2009.Kobayashi, K, Ramirez, P, Kim, E, Levenback, F, Rohren, E, Frumovitz, M, Mar, M, Gayed, I: Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med, 34(12): 859-61, December 2009. Roth, ES, Fetzer, DT, Barron BJ, Joseph, UA, Gayed, IW, Wan, DQ. Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer, 9:274 August 2007.Fearmonti, RM, Gayed, IW, Kim, E, Bedrosian, I, Hunt, KK, Meric-Bernstam, F, Feig, B, Ghonimi, E, Warneke, C, Babiera, GV. Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann. Surg. Oncol 17(1):220-7, January 2010.Gayed, I, Wahba, H, Wan, D, Joseph, UA, Murthy, R. Effect of Y-90 SIR-spheres therapy for multiple liver metastases in a variety of tumors. J Cancer Sci Ther, 2(2):43-46, March 2010.Gayed, IW, Raslan, OA, Bhosale, PR, Perrier, ND, Wei, W, Gladish, G. Significant coronary calcification detected using contrast-enhanced computed tomography: Is it an indication for further investigation? Clin Nucl Med, 35(6):404-8, June 2010.Camacho; LH, Garcia; S, Panchal; AM, Lim, J, Hong; HS, Ng, C, Madoff; DC, Fu; S, Gayed; I, Kurzrock, R : Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in refractory solid tumor patients with extensive liver metastases. Clinical Colorectal Cancer, 9(5):311-4, December 2010.Gayed, IW. Editorial. Research and Reports in Nuclear Medicine, 1(1):9-10 June 2011.Gayed, I, Kim, EE, Awad, J, Joseph, UA, Wan, DQ, John, SD. The value of fused SPECT/CT in the evaluation of solitary skull lesion. Clin Nucl Med, 36(7):538-41 July 2011.Gayed, I, Wan D, Beasley C, Joseph U, Awad J, and John S. Impact of bone SPECT-CT imaging on evaluation of lower extremities’ abnormalities. Research and Reports in Nuclear Medicine, 2:1-9, 2012.Joseph, UA, Kothari, K, Skolkin, D, Wan, DQ, Gayed, IW. Technetium-99m ethylene cysteine dimer posterior fossa perfusion and brain death. Research and Reports in Nuclear Medicine, 2:11-15, 2012.Kim, HW, Won, KS, Zeon, SK, Ahn, BC, Gayed, IW. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clin Nucl Med, 38(2):93-7, February 2013.Isis Gayed, Usha Joseph, Mina Fanous, David Wan, Mya Schiess, William Ondo, Kyoung-Sook Won, "The Impact of DaTscan in the Diagnosis of Parkinson Disease." Clin Nucl Med, 40(5):390-3, May 2015.Isis W. Gayed, Ron J. Karni, David Q. Wan, Jeena M. Varghese, Kelly L. Wirfel, Kyoung-Sook Won, Usha A. Joseph. Interpretation of Tc-99m Sestamibi Parathyroid SPECT CT Scans Made Easy for Better Surgical Outcomes in Patients with Primary Hyperparathyroidism. Reports in Medical Imaging. 2016:9.Usha A. Joseph, Ron J. Karni, David Q. Wan, Isis W. Gayed. Limited PET/CT– A New Concept in Follow-up of Head and Neck Cancer Patients. Journal of Molecular Medicine and Clinical Applications. 2(1):1-5, June 2018. Gayed, Vivian Salama, Lydia Dawood, Steven Canfield, David Wan, Chunyan Cai, Usha Joseph, Robert Amato. Can bone scans guide therapy with Radium 223 Dichloride for patients with castrate resistant bony metastases. Cancer Manag Res. 2018 Sep 7;10:3317-3324.Susana Calle, Lydia Dawood, Niroj Tripathee, Chunyan Cai, Harleen Kaur, David Wan, Henry Ibekwe, Isis Gayed. Identification of patterns of abnormalities seen on DaTscan SPECT imaging in patients with non-Parkinson movement disorders. Reports in Medical Imaging. 12:9-15, July 2019.Rashad Johnson, Grace Rizk, Omotola Hope, Harleen Kaur, Henry Ibekwe, Monica Atta, Isis Gayed. PET CT and PET-MRI Fusion: Can they help predict surgical outcome in Epilepsy patients?. Journal of Neuroadiology. Oct 22, 2019. Gayed, Lydia Dawood, Zhang Xu, Grace Rizk, Andrew Dupont, Monica Atta, Emily Robinson, MD. Improving Hepatobiliary Imaging as a Physiologic Test with Superior Clinical Outcomes. In press.Book Chapters:Gayed, Isis. Nuclear Cardiac Imaging in Cancer Patients. In: Cancer and the Heart. BC Decker Inc. – 2006.Scientific Session Presentations at National/International Meetings:Gayed, I. Investigation of Tc-99m Labeling of L-Methionine for SPECT Imaging of Tumors. Society of Nuclear Medicine Annual Meeting, Washington, DC, June 1990.Gayed, I. Routine first-pass left ventricular studies during stress with Sestamibi using a single-crystal gamma camera. Eastern Great Lakes Chapter-Society of Nuclear Medicine Annual Meeting, Niagra Falls, NY, April 1992.Gayed, I. Timing for retreatment of hyperthyroidism with radioactive iodine after initial treatment failure. Society of Nuclear Medicine Annual Meeting, Toronto, Canada, June 1998.Scientific Session Moderator, Southwest Chapter-Society of Nuclear Medicine 44th Annual Meeting, 1999Gayed, I. Factors affecting the accuracy of left ventricular ejection fraction using quantitative gated SPECT (QGS). Southwest Chapter-Society of Nuclear Medicine Annual Meeting, New Orleans, LA, March 2001.Gayed, I., Sentinel Lymph Node Mapping. Continuing Education Program, Radiological Society of North America, Chicago, IL, December 2002.Gayed, I., Sentinel Lymph Node Mapping. Continuing Education Program, Radiological Society of North America, Chicago, IL, December 2003.Gayed, I., Effect of Iterative Reconstruction on Left Ventricular Ejection Fraction and Volumes, Society of Nuclear Medicine Annual Meeting, Philadelphia, PA, June 2004.Gayed, I., The Value of SPECT/CT for the Evaluation of Parathyroid Adenoma, Society of Nuclear Medicine Annual Meeting, Philadelphia, PA, June 2004.Gayed, I., Comparison Between I-123 MIBG and In-111 Octreotide in the Detection of Neuroendocrine Tumors, Society of Nuclear Medicine Annual Meeting, Philadelphia, PA, June 2004.Sentinel Lymph Node Mapping: Controversies. Continuing Education Course, RSNA, Chicago, December 2004Gayed, I., Preoperative risk stratification of cancer patients using stress dual isotope gated myocardial perfusion imaging. Society of Nuclear Medicine Annual Meeting, Toronto, Canada, June 2005.Gayed, I., Lymphatic Drainage Patterns from Breast Cancer: A Large Cancer Center Experience. Society of Nuclear Medicine Annual Meeting, Toronto, Canada, June 2005.Gayed, I., Lung perfusion SPECT/CT can predict future pulmonary complications Prior to Radiation Therapy in Patients with Lung Cancer. Society of Nuclear Medicine Annual Meeting, Washington, DC. June 2007.Gayed, I., Chemoradiation Induced Myocardial Perfusion Abnormalities and Clinical Outcomes in Patients with Esophageal Cancer. Society of Nuclear Medicine Annual Meeting, Washington, DC. June 2007.Gayed, I., Lung Perfusion Score Can Predict Future Pulmonary Complications After Radiation Therapy in Patients with Lung Cancer. ASTRO, San Diego, CA. October 2007.Gayed I., Value of Positron Emission Tomography in Evaluating Response to Therapy of Orbital and Ocular Adnexal Lymphomas. Am Soc Opthalm Plast Recon Surgery Fall Annual Symposium, New Orleans, IN November 2007.Gayed I., Is Coronary Arteries Calcification on Chest Computed Tomography Scans an Indication for Stress Myocardial Perfusion Studies? Radiological Society of North America, Chicago, IL, December 2008.Gayed, I., The Value of Fused Single Photon Emission Computed Tomography (SPECT) With Computed Tomography (CT in the Evaluation of Solitary Skull Lesion. Society of Nuclear Medicine Annual Meeting in Toronto, Canada, June 2009.Gayed, I., Impact of bone SPECT-CT imaging on evaluation of lower extremities pathology. The Society of Nuclear Medicine Annual Meeting in San Antonio, Texas, June 2011. Gayed, I.,Tc-99m Sestamibi parathyroid SPECT-CT scans is the only diagnostic study required in most patients with primary hyperparathyroidism. The Society of Nuclear Medicine Annual Meeting in Baltimore, Maryland, June 2015.Gayed, I., Is Cholecystokinin Administration During Hepatobiliary Imaging A Physiologic Test? SNMMI Annual Meeting, Denver, June, 2017Gayed I, Improving Hepatobiliary Imaging As A Physiologic Test with Superior Clinical Outcomes, SNMMI Annual Meeting, Philadelphia, June, 2018Other Scientific Presentations in Different Institutions:Artifacts in Nuclear Medicine. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, February 1998.Fun with artifacts. Nuclear Medicine Technologists of Houston Fall Symposium, Houston, TX, October 1998.Effects of Medication on Nuclear Medicine Studies. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, February 1999.I-123 MIBG Myocardial Imaging. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, May 1999.FDG Myocardial Imaging. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, February 2000.FDG Imaging of Lymphoma. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, December 2000.Bone Versus FDG Scans for the Evaluation of Bony Metastases. Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, December 2001.Bone Mineral Density, the convention, the Interpretations and the Practice, Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, April 2002.What Is Nuclear Medicine? Houston Baptist University Alpha Epsilon Delta Pre-Medical Honor Society, Houston, TX, Nov. 2002.Breast Lymphatic Mapping Course, American College of Surgeons Oncology Group, University of Texas – MD Anderson Cancer Center, Houston, TX, 09/26-27/02.Gastrointestinal Stromal Tumors and FDG PET Imaging, Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, November 2002.The Role of Nuclear Medicine in Head and Neck Cancers, Department of Head & Neck Surgery, UT MD Anderson Cancer Center, Houston, TX, April 2003.Sentinel Lymph Node Mapping in Breast Cancer, Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, November 2003.Cardiac PET, echocardiography Seminars, UT MD Anderson Cancer Center, Houston, TX, February 2004.Advances in Cardiac Imaging, Seminars in Nuclear Medicine, UT MD Anderson Cancer Center, Houston, TX, February 2004.Moderator, Multidisciplinary Conference, UT-MD Anderson Cancer Center, Houston, Texas February 2004Nuclear Medicine and Radiation Cardiotoxicity, Radiation Oncology Research Seminars, UT MD Anderson Cancer Center, Houston, TX, April 20053D-Lung Perfusion Imaging, Radiation Oncology Research Seminars, UT MD Anderson Cancer Center, Houston, TX, September 2005Functional Lung Imaging for Radiation Therapy Planning, Experimental Nuclear Medicine Seminars, UT MD Anderson Cancer Center, Houston, TX, October 2005Coronary Artery Disease and Primary Hyperparathyroidism. Parathyroid Multimodality Seminars, UT MD Anderson Cancer Center, Houston, TX, November 2008.Primary Hyperparathyroidism and Coronary Artery Disease. Multi-disciplinary parathyroid conference. UT- M. D. Anderson Cancer Center, Houston, TX November 2008.Parathyroid Scintigraphy. Endocrinology Seminars, UTHSC at Houston, TX February 2009.PET Imaging for the Cardiothoracic Surgeon, Grand Rounds for Department of Cardiothoracic Surgery, UTHSC at Houston, TX April 2009.Nuclear Imaging of Neurological Disorders, Grand Rounds for the Department of Neurology, UTHSC Medical School at Houston, Texas October 2009.Thyroid Cancer and Nuclear Medicine, Core Curriculum Lecture, Department of Endocrinology, UTHSC Medical School at Houston, Texas January 2010.Radionuclides therapies in Oncology, Oncology Grand Rounds, UTHSC, Houston, TX June 2011.Parathyroid Imaging, ENT Conference, UTHSC, Houston, TX June 2013.Thyroid Cancer Imaging, Texas Chapter of Society of Nuclear Medicine, Houston, TX October, 2013.Imaging of Neuroendocrine tumors, Oncology Grand Rounds, UTHSC, Houston, TX March 2014.PET Brain Imaging. Neuroradiology Fellowship Lecture Series. UTHSC, Houston, TX May 2014.Brain Imaging in Nuclear Medicine: Radiology Week presentations. MHH, Houston, TX Nov, 2014.Early Experience with Ra- 223 Xofigo Therapy. Oncology Retreat, UTHSC, Houston, TX Oct, 2015.Accuracy Versus Efficiency in Myocardial Perfusion Imaging, Cooley Visiting Professor Lecture, UTMB, Galveston, TX Dec, 2015Thyroid Cancer Imaging in Nuclear Medicine, Endocrine Conference, UT-Health, Houston, TX April, 2019Predicting Surgical Outcomes in Patients with Refractory Seizures Using PET-CT and PET-MRI Fused Images. Frist Annual Research Retreat. Department of Interventional and Diagnostic Imaging, UT-Health, Houston, TX Feb, 2020Scientific Exhibits:Tc-99m MIBI myocardial perfusion scintigraphy in patients with left bundle branch block (Poster). Southwest Chapter-Society of Nuclear Medicine Annual Meeting, Houston, TX, April 1998.Patterns of Tc-99m MIBI, Tc-99m anti-CEA and F-18 FDG uptake in various breast conditions, benign and malignant (Computer Exhibit). Society of Nuclear Medicine Annual Meeting, June 1998.Quantification of right ventricular ejection fraction with gated myocardial perfusion imaging (Poster). European Association of Nuclear Medicine Annual Meeting, Paris, France, September 2000.Convenient quantification of right ventricular ejection fraction as part of the routine gated myocardial perfusion studies (Poster). American Heart Association Annual Meeting, New Orleans, LA, November 2000.Correlation of left ventricular ejection fraction using gated SPECT automated programs with echocardiography (Poster). Society of Nuclear Medicine Annual Meeting, Toronto, Canada, June 2001.Effect of myocardial perfusion defects on the accuracy of left ventricular ejection fraction using gated SPECT (Poster). American Heart Association Annual Meeting, Anaheim, CA, November 2001.Positron emission tomography versus computerized tomography for identification of melanoma metastases (Poster). Society of Nuclear Medicine 49th Annual Meeting, Los Angeles, CA, June parison of bone and F-18 FDG scans in the evaluation of bony metastases (Poster). Society of Nuclear Medicine 49th Annual Meeting, Los Angeles, CA, June parison of resting echocardiography and gated SPECT in the evaluation of wall motion abnormalities (Poster). 7th Annual American Society of Nuclear Cardiology Symposium and Scientific Session, Baltimore, MD, June parison Between Iterative Versus Filtered Backprojection Processing of Myocardial Perfusion Studies. Society of Nuclear Medicine 51st Annual Meeting, Philadelphia, PA, June 2004The Biodistribution of Annexin V in the Hearts of Patients Receiving Chemotherapy for Breast Cancer. Academy of Molecular Imaging, Orlando, Fl, March 2006.Inferior Wall Myocardial Ischemia after Concurrent Chemoradiation Therapy in Patients with Distal Esophageal Cancer. American Society of Nuclear Cardiology. Montreal, Canada, September 2006Treatment of Multiple Liver Metastases with Y-90 SIR Spheres: The Experience of a Large Cancer Canter. Society of Nuclear Medicine 54th Annual Meeting, New Orleans, LA, June 2008DaTscan is a robust imaging modality for evaluation of patients with movement disorders. Society of Nuclear Medicine 59th Annual Meeting, Miami, FL June 2012.The impact of DaTscan in different clinical presentations of movement disorders. Society of Nuclear Medicine 61st Annual Meeting, St Louis, MO June 2014.Value of Electroencephalograms for PET Scan Interpretation in Patients with Seizure Disorders. World Federation of Nuclear Medicine and Biology Annual Meeting, Cancun, Mexico August 2014.Early Experience with Radium 223 Xofigo Therapy in Patients with Prostate Bony Metastases. World of Molecular Imaging Congress, Honolulu, Hawaii Sept 2015.Optimizing Patient Selection for Therapy with Radium 223 Dichloride. Society of Nuclear Medicine 63rd Annual Meeting, San Diego, CA June 2016.Is Cholecystokinin Administration During Hepatobiliary Imaging A Physiologic Test? Society of Nuclear Medicine 64th Annual Meeting, Denver, CO June 2017.Quantification of Tc-99m MAA liver perfusion as a predictive of tumor response to Yittrium 90 spheres. Electronic scientific exhibit, ARRS 118th meeting, Washington D.C. Apr, 2018Visiting Professorships:Effects of Various Chemical Agents on Biodistribution of Radiopharmaceuticals. Nuclear Medicine Service, St. Luke’s Episcopal Hospital, Houston, TX, 08/1998.Radiation for the Non-Radiologist. Bay City General Hospital, Bay City, TX, 09/1998.Tc-99m NEOT, A New Myocardial Perfusion Imaging Radiopharmaceutical. Nuclear Medicine Service, St. Luke’s Episcopal Hospital, Houston, TX, 01/1999.Right Ventricular Uptake of Tc-99m Labeled Myocardial Perfusion Agents. Nuclear Medicine Service, St. Luke’s Episcopal Hospital, Houston, TX, 08/1999.Characteristics of Radiopharmaceutical – Annual Jeopardy. Nuclear Medicine Service, St. Luke’s Episcopal Hospital, Houston, TX, 01/2000.The Value of PET and PET/CT Imaging in Staging and Monitoring of Therapy Effects in Orbital Cancers. UT- M. D. Anderson Cancer Center. Houston, TX, 03/2009.Consultant:G.E. Healthcare System for Brain Imaging with DAT-Scan – 2009Avid Radiopharmaceuticals Inc. for Amyvid study - Nov 2013.UTMB - Nuclear Cardiology Team Advisor- Dec 2015. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download